These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29333904)

  • 21. The assessment of RBE effects using the concept of biologically effective dose.
    Dale RG; Jones B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):639-45. PubMed ID: 10078651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
    Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions.
    Wilkens JJ; Oelfke U
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):262-6. PubMed ID: 17935903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative Biological Effectiveness Uncertainties and Implications for Beam Arrangements and Dose Constraints in Proton Therapy.
    Paganetti H; Giantsoudi D
    Semin Radiat Oncol; 2018 Jun; 28(3):256-263. PubMed ID: 29933885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of linear energy transfer distribution for broad-beam carbon-ion radiotherapy at the National Institute of Radiological Sciences, Japan.
    Kanematsu N; Matsufuji N; Inaniwa T
    Radiol Phys Technol; 2018 Jun; 11(2):242-247. PubMed ID: 29470773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of secondary particles to the dose in 12C radiotherapy and other heavy ion beams.
    Jadrnícková I; Spurny F; Molokanov AG
    Radiat Prot Dosimetry; 2007; 126(1-4):657-9. PubMed ID: 17504750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological dose representation for carbon-ion radiotherapy of unconventional fractionation.
    Kanematsu N; Inaniwa T
    Phys Med Biol; 2017 Feb; 62(3):1062-1075. PubMed ID: 28081010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams.
    Kempe J; Gudowska I; Brahme A
    Med Phys; 2007 Jan; 34(1):183-92. PubMed ID: 17278503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes.
    Carabe-Fernandez A; Dale RG; Hopewell JW; Jones B; Paganetti H
    Phys Med Biol; 2010 Oct; 55(19):5685-700. PubMed ID: 20826903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beam interruption time on tumor control probability in single-fractionated carbon-ion radiotherapy for non-small cell lung cancer.
    Inaniwa T; Kanematsu N; Suzuki M; Hawkins RB
    Phys Med Biol; 2015 May; 60(10):4105-21. PubMed ID: 25933161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational models and tools.
    Schuemann J; Bassler N; Inaniwa T
    Med Phys; 2018 Nov; 45(11):e1073-e1085. PubMed ID: 30421814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the sensitivity to ion therapy based on the response to photon irradiation--experimental evidence and mathematical modelling.
    Mohanty C; Zielinska-Chomej K; Edgren M; Hirayama R; Murakami T; Lind B; Toma-Dasu I
    Anticancer Res; 2014 Jun; 34(6):2801-6. PubMed ID: 24922642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.
    Fuchs H; Alber M; Schreiner T; Georg D
    Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.
    Fossati P; Molinelli S; Matsufuji N; Ciocca M; Mirandola A; Mairani A; Mizoe J; Hasegawa A; Imai R; Kamada T; Orecchia R; Tsujii H
    Phys Med Biol; 2012 Nov; 57(22):7543-54. PubMed ID: 23104051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
    Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doses and LET spectra in the beam of 12C with energy 500 MeV amu-1.
    Jadrnícková I; Molokanov AG; Spurny F
    Radiat Prot Dosimetry; 2006; 122(1-4):488-90. PubMed ID: 17218367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the use of effective dose in the treatment planning of high linear-energy-transfer radiation.
    Lam GK
    Med Phys; 1989; 16(5):687-91. PubMed ID: 2509863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.